Revenue from the company's main growth driver, Optum unit, which manages drug benefits and offers healthcare data analytics services, rose 10% to $36.4 billion.
The company reported adjusted earnings of $5.31 per share, beating estimates of $4.38 per share, according to IBES data from Refinitiv.
Optimism nevertheless appeared intact among traders as bitcoin zoomed to a record high above $63,000 ahead of Wednesday's trading launch of the Coinbase cryptocurrency exchange.
On April 7, DRAP had stopped both the centers from administering Sputnik V, saying that they deviated from the recommended storage temperature of the vaccine.
The planned orders will be for so-called mRNA vaccines, with a preference for manufacturers who are EU-based or who have production facilities in Europe.
Only the Biontech/Pfizer vaccine, which is manufactured in Belgium and Germany, and Moderna, which manufactures in Spain and Switzerland, currently meet these requirements.
Imran says Russia's move to hosting the recent meeting of Extended Troika in Moscow is an important step in this regard
Premier reaffirmed Pakistan's resolve to expeditiously conclude the requisite legal process for the Pakistan Stream (North-South) Gas Pipeline project and commence the work as early as possible
“Our results indicate that brain diseases and psychiatric disorders are more common after COVID-19 than after flu or other respiratory infections,” said Max Taquet, a psychiatrist at Britain’s Oxford University, who co-led the work.
The resolution urged the government to provide either free-of-cost coronavirus vaccine or as per the original international market price to the general public.
"We will...support the Czech Republic bilaterally with 30,000 doses of vaccine and believe it is very positive that we have also heard that other European countries are prepared to do the same," it said. Kurz previously said an EU deal on Thursday on dose distribution should have given the Czech Republic more.
"Senior citizen above 65 years can now walk in to any designated vaccination center with their CNIC to get on spot registration and vaccination, with effect from 3rd April 21," NCOC said.
The vaccination drive to inoculate those 60 and above began on March 10.
"The production of our core product is much more complicated (than vaccine)," Mabion board member Adam Pietruszkiewicz told.
"We still have to buy some equipment intended solely for the production of vaccines. However, our main machine park is ready. After completing this process, we should enter the commercial production phase at the beginning of the second half of the year," Pietruszkiewicz said.
"Received 5 lakh 60 thousand procured vaccines yesterday. Another 5 lakhs will arrive tonight," Asad Umar tweeted.
At least 452000 shots of Sinopharm and CanSino vaccine have been provided to Punjab, Sindh, Khyber Pakhtunkhwa, Balochistan, Islamabad, Azad Jammu and Kashmir, and Gilgit-Baltistan.
CanSinoBIO’s chief scientific officer says a second shot given to trial participants six months after their first injection could offer substantial protection against the virus
Tao says accurate and precise results could only be gathered after more clinical trials
The vaccine jabs were transported in the cold-chain containers via road and by air
At least 452000 shots of Sinopharm and CanSino vaccine have been provided to Punjab, Sindh, Khyber Pakhtunkhwa, Balochistan, Islamabad, Azad Jammu and Kashmir, and Gilgit-Baltistan
The J&J vaccine has won praise for its single dosage and because it does not need to be frozen -- unlike the shots from Moderna and Pfizer -- making distribution much simpler.
Conservative leader Kurz is under fire from opposition parties because his government did not buy as many coronavirus vaccines as it could have under the European Union's collective purchasing scheme.
"There must be no geopolitical blinkers regarding vaccines," Kurz said in a statement issued by his office, adding that Austria is in talks with Russia and Moscow has offered to sell it a million doses as of April. "The only thing that must count is whether the vaccine is effective and safe."